# Functional Implications of Rare Gene Mutations in aHUS Open the Door to Personalized Therapy

> **NCT05805202** · NA · RECRUITING · sponsor: **Mario Negri Institute for Pharmacological Research** · enrollment: 112 (estimated)

## Conditions studied

- Atypical Hemolytic Uremic Syndrome

## Interventions

- **OTHER:** Blood sampling and urine analysis

## Key facts

- **NCT ID:** NCT05805202
- **Lead sponsor:** Mario Negri Institute for Pharmacological Research
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-05-03
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 112 (ESTIMATED)
- **Last updated:** 2025-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05805202

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05805202, "Functional Implications of Rare Gene Mutations in aHUS Open the Door to Personalized Therapy". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05805202. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*